Drug application
SODIUM CHLORIDE 14.6% (SODIUM CHLORIDE)
Drugs@FDA ANDA 212070 · FRESENIUS KABI USA
Key facts
| Drug name | SODIUM CHLORIDE 14.6% |
|---|---|
| Active ingredients | SODIUM CHLORIDE |
| Application type | ANDA |
| Application number | 212070 |
| Company | FRESENIUS KABI USA |
| Dosage forms | SOLUTION, INTRAVENOUS |
| Strength | 50MEQ/20ML (2.5MEQ/ML) |
| Marketing status | Prescription |
| Reference listed drug | No |
| Latest submission status date | Apr 28, 2021 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- No FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: